Update on cultured autologous tumor cells and dendritic cells as patient-specific vaccines in recurrent or metastatic melanoma or renal cell cancer

被引：0
|
作者：
Dillman, R [1 ]
Selvan, S [1 ]
Schiltz, P [1 ]
Allen, K [1 ]
DePriest, C [1 ]
Beatty, A [1 ]
de Leon, C [1 ]
Beutel, L [1 ]
Peterson, C [1 ]
Ellis, R [1 ]
机构：
[1] Hoag Mem Hosp Presbyterian, Hoag Canc Ctr, Newport Beach, CA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2003年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [41] Autologous tumor cell line-derived vaccine for patient-specific treatment of advanced renal cell carcinoma
    Dillman, R
    Barth, N
    VanderMolen, L
    Mahdavi, K
    Beutel, L
    de Leon, C
    DePriest, C
    Nayak, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (05) : 570 - 580
  • [42] Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy: A Randomized Phase II Trial of Dendritic Cells Versus Tumor Cells in Patients With Metastatic Melanoma
    Dillman, Robert O.
    Cornforth, Andrew N.
    DePriest, Carol
    McClay, Edward F.
    Amatruda, Thomas T.
    de Leon, Cristina
    Ellis, Robin E.
    Mayorga, Cheryl
    Carbonell, Denysha
    Cubellis, James M.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (08) : 641 - 649
  • [43] Patient-specific dendritic cell immunization against tumor in Sezary syndrome
    Geskin, L. J.
    Akilov, O. E.
    Butterfield, I.
    Whiteside, T. L.
    Falo, L. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S56 - S56
  • [44] CHARACTERIZATION OF AUTOLOGOUS TUMOR-SPECIFIC T-HELPER-2 CELLS IN TUMOR-INFILTRATING LYMPHOCYTES FROM A PATIENT WITH METASTATIC MELANOMA
    KHARKEVITCH, DD
    SEITO, D
    BALCH, GC
    MAEDA, T
    BALCH, CM
    ITOH, K
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (03) : 317 - 323
  • [45] Electro-fusion of dendritic cells with tumor cells: Development of cell-based cancer vaccines
    Orentas, RJ
    Schauer, D
    Johnson, B
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 86 - 86
  • [46] Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumor
    Wang, QJ
    Hanada, K
    Perry-Lalley, D
    Bettinotti, MP
    Karpova, T
    Khong, HT
    Yang, JC
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 551 - 559
  • [47] Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines
    Mulders, P
    Tso, CL
    Gitlitz, B
    Kaboo, R
    Hinkel, A
    Frand, S
    Kiertscher, S
    Roth, MD
    deKernion, J
    Figlin, R
    Belldegrun, A
    CLINICAL CANCER RESEARCH, 1999, 5 (02) : 445 - 454
  • [48] Development and therapeutic effect of adoptively transferred T cells primed by tumor lysate-pulsed autologous dendritic cells in a patient with metastatic endometrial cancer
    Santin, AD
    Hermonat, PL
    Ravaggi, A
    Bellone, S
    Cowan, C
    Coke, C
    Pecorelli, S
    Cannon, MJ
    Parham, GP
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 49 (03) : 194 - 203
  • [49] Autologous tumor cell pulsed - Dendritic cells as tumor vaccine.
    Kojima, M
    Morisaki, T
    Katano, M
    Nakamura, M
    Tanaka, M
    Torisu, M
    FASEB JOURNAL, 1997, 11 (03): : 3155 - 3155
  • [50] Natural killer cells as helper cells in dendritic cell cancer vaccines
    Betina Pampena, Maria
    Mariel Levy, Estrella
    FRONTIERS IN IMMUNOLOGY, 2015, 6
12345